10-101228593-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_006562.5(LBX1):c.223G>A(p.Gly75Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000173 in 1,557,616 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_006562.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LBX1 | NM_006562.5 | c.223G>A | p.Gly75Ser | missense_variant | 1/2 | ENST00000370193.4 | NP_006553.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LBX1 | ENST00000370193.4 | c.223G>A | p.Gly75Ser | missense_variant | 1/2 | 1 | NM_006562.5 | ENSP00000359212.2 |
Frequencies
GnomAD3 genomes AF: 0.0000788 AC: 12AN: 152224Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000377 AC: 6AN: 159124Hom.: 0 AF XY: 0.0000469 AC XY: 4AN XY: 85352
GnomAD4 exome AF: 0.0000107 AC: 15AN: 1405280Hom.: 0 Cov.: 32 AF XY: 0.0000115 AC XY: 8AN XY: 693626
GnomAD4 genome AF: 0.0000788 AC: 12AN: 152336Hom.: 0 Cov.: 33 AF XY: 0.0000940 AC XY: 7AN XY: 74492
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 03, 2024 | The c.223G>A (p.G75S) alteration is located in exon 1 (coding exon 1) of the LBX1 gene. This alteration results from a G to A substitution at nucleotide position 223, causing the glycine (G) at amino acid position 75 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at